UNCY Unicycive Therapeutics, Inc. - Common Stock
$7,87
Cena · Maj 20, 2026
Dane fundamentalne na dzień Maj 12, 2026
Zakres 52 tyg.
$4–$11
57% of range
Ocena Analityków
BUY
14 analysts
Cena Docelowa
$41
+421% upside
P/E (TTM)
-3.5
ROE
-113.9%
Marża Zysku Netto
—
UNCY Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$7.87
Kapitalizacja Rynkowa
$128M
P/E (TTM)
-3.5
EPS (TTM)
$-1.67
Przychody (TTM)
—
Stopa dywidendy
—
ROE
-113.9%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$4 – $11
UNCY Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
—
2022-12-31
→
2023-12-31
EPS
$-1.67
2021-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-31M
2022-12-31
→
2025-12-31
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
UNCY
Mediana porównawcza
P/E (TTM)
-3.5
2.4
P/B
4.2
1.4
Price / FCF (Cena / FCF)
-4.1
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
UNCY
Mediana porównawcza
ROA
-65.7%
-52.8%
ROE
-113.9%
-60.2%
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
UNCY
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
2.6
7.4
Quick Ratio (Wskaźnik Szybkości)
2.2
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
UNCY
Mediana porównawcza
Revenue YoY (Przychody R/R)
-29.0%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
UNCY
Mediana porównawcza
UNCY Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
14 analityków
- Mocne kupno 3 21,4%
- Kup 10 71,4%
- Trzymaj 1 7,1%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
10 analityków · 2026-05-20
Mediana
$33.50
Średnia
$40.99
← Poniżej wszystkich celów
$7.87
Niski
$15.00
Wysoki
$90.00
Średni cel
$33.50
+325,7%
Średnia cel
$40.99
+420,9%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.15%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $-0.54 | $-0.52 | -0.02% |
| 31 grudnia 2025 | $-0.82 | $-0.48 | -0.34% |
| 30 września 2025 | $-0.33 | $-0.57 | 0.24% |
| 30 czerwca 2025 | $-0.52 | $-0.75 | 0.23% |
| 31 marca 2025 | $-0.50 | $-1.16 | 0.66% |
| 31 grudnia 2024 | $-2.60 | $-0.92 | -1.7% |
Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| UNCY | $128M | -3.5 | -29.0% | — | -113.9% | — |
| IKT | $270M | -4.2 | 111.0% | -1299.0% | -38.2% | — |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | — |
| NERV | $174M | -0.1 | — | — | 339.5% | — |
| BDTX | $139M | 6.2 | — | 31.9% | 18.3% | — |
| KROS | $398M | 8.9 | — | 35.7% | 17.2% | — |
| NKTX | $131M | -1.3 | — | — | -31.1% | — |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | — |
| ANIK | $133M | -12.6 | -5.9% | -9.6% | -7.5% | 56.6% |
| ARTV | — | -1.3 | -99.2% | — | — | — |
| HUMA | — | — | — | — | — | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | · | · | $675.0K | $951.0K | |
| R&D Expense | $9M | $20M | $13M | $12M | |
| SG&A Expense | $20M | $12M | $9M | $7M | |
| Operating Expenses | $30M | $32M | $21M | $19M | |
| Operating Income | $-30M | $-32M | $-21M | $-18M | |
| Interest Expense | · | · | $82.0K | $6.0K | |
| Interest Income | $1M | $1M | $615.0K | · | |
| Other Non-op | $3M | $-5M | $-10M | $-6.0K | |
| Net Income | $-27M | $-37M | $-31M | $-18M | |
| EPS (Basic) | $-1.67 | $-5.65 | $-1.28 | $-1.20 | |
| EPS (Diluted) | $-1.67 | $-5.65 | $-1.28 | $-1.20 | |
| Shares (Basic) | 15,886,876 | 6,698,513 | 24,539,309 | 15,057,049 | |
| Shares (Diluted) | 15,886,876 | 6,698,513 | 24,539,309 | 15,057,049 | |
| EBITDA | $-30M | $-32M | $-21M | $-18M |
Bilans 21
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $29M | $26M | $10M | $455.0K | |
| Short-term Investments | $12M | · | · | · | |
| Inventory | · | · | · | $2M | |
| Prepaid Expense | $8M | $5M | $4M | $2M | |
| Current Assets | $49M | $31M | $13M | $3M | |
| PP&E (Net) | $66.0K | $75.0K | $26.0K | $22.0K | |
| PP&E (Gross) | $138.0K | $114.0K | $42.0K | $29.0K | |
| Accum. Depreciation | $72.0K | $39.0K | $16.0K | $7.0K | |
| Total Assets | $49M | $32M | $14M | $3M | |
| Accounts Payable | $383.0K | $1M | $839.0K | $892.0K | |
| Accrued Liabilities | $2M | $4M | $3M | $2M | |
| Current Liabilities | $19M | $24M | $18M | $3M | |
| Capital Leases | · | $117.0K | $466.0K | · | |
| Total Liabilities | $19M | $24M | $18M | $3M | |
| Common Stock | $22.0K | $11.0K | $35.0K | $15.0K | |
| Paid-in Capital | $158M | $109M | $61M | $34M | |
| Retained Earnings | $-128M | $-101M | $-65M | $-34M | |
| AOCI | $-1.0K | · | · | · | |
| Stockholders' Equity | $30M | $7M | $-4M | $-466.0K | |
| Liabilities + Equity | $49M | $32M | $14M | $3M | |
| Shares Outstanding | 22,114,245 | 11,384,236 | 34,756,049 | 15,231,655 |
Przepływy pieniężne 11
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | · | · | · | $428.0K | |
| Stock-based Comp | $3M | $2M | $2M | $1M | |
| Other Non-cash | · | · | · | $932.0K | |
| Operating Cash Flow | $-31M | $-29M | $-18M | $-16M | |
| CapEx | $24.0K | $72.0K | $12.0K | $2.0K | |
| Investing Cash Flow | $-12M | $-72.0K | $-12.0K | $-2.0K | |
| Stock Issued | · | · | · | $11.0K | |
| Dividends Paid | · | $1M | · | · | |
| Financing Cash Flow | $46M | $45M | $28M | $-471.0K | |
| Net Change in Cash | · | · | · | $-16M | |
| Free Cash Flow | $-31M | $-29M | $-18M | $-16M |
Rentowność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | · | · | -3077.6% | -1898.2% | |
| Net Margin | · | · | -4525.0% | -1898.8% | |
| EBITDA Margin | · | · | -3077.6% | -1853.2% | |
| ROA | -65.7% | -160.2% | -359.1% | -167.5% | |
| ROE | -113.9% | 359.8% | 16290.1% | -868.2% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 2.6 | 1.3 | 0.8 | 0.8 | |
| Quick Ratio | 2.2 | 1.1 | 0.6 | 0.1 | |
| Interest Coverage | · | · | -253.3 | -3008.7 |
Efektywność 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.1 | 0.1 |
Stopy Wzrostu 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | · | · | -29.0% | · |
Wycena (TTM) 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | · | · | $675.0K | $951.0K | |
| Net Income TTM | $-27M | $-37M | $-31M | $-18M | |
| Market Cap | $128M | $904M | $302M | $82M | |
| P/E | -3.5 | -1.4 | -6.8 | -4.5 | |
| P/S | · | · | 446.9 | 86.5 | |
| P/B | 4.2 | 121.6 | -79.2 | -176.5 | |
| P / Tangible Book | 4.2 | 121.6 | · | · | |
| P / Cash Flow | -4.1 | -31.6 | -16.5 | -5.3 | |
| P / FCF | -4.1 | -31.6 | -16.5 | -5.3 | |
| Dividend Yield | · | 0.12% | · | · | |
| Earnings Yield | -28.9% | -71.2% | -14.8% | -22.2% | |
| Payout Ratio | · | -3.0% | -2.9% | · | |
| Annual Payout | · | $1M | · | · |
Rachunek zysków i strat 14
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | $0 | · | · | $675.0K | $0 | $951.0K | |
| R&D Expense | $2M | $2M | $3M | $2M | $2M | $5M | $3M | $5M | $7M | $4M | $3M | $2M | $3M | $4M | $5M | |
| SG&A Expense | $7M | $5M | $4M | $5M | $6M | $4M | $3M | $3M | $2M | $2M | $3M | $2M | $2M | $6M | $163.0K | |
| Operating Expenses | $8M | $7M | $7M | $7M | $8M | $9M | $6M | $7M | $9M | $6M | $6M | $4M | $5M | $5M | $7M | |
| Operating Income | $-8M | $-7M | $-7M | $-7M | $-8M | $-9M | $-6M | $-7M | $-9M | $-6M | $-6M | $-4M | $-4M | $-5M | $-6M | |
| Interest Expense | · | · | · | · | · | · | · | · | $20.0K | · | $18.0K | $32.0K | $12.0K | $3.0K | $3.0K | |
| Interest Income | $394.0K | $352.0K | $279.0K | $155.0K | $226.0K | $314.0K | $416.0K | $462.0K | $69.0K | $140.0K | $227.0K | $234.0K | $14.0K | · | · | |
| Other Non-op | $-4M | $-7M | $1M | $516.0K | $9M | $-12M | $2M | $17M | $-12M | $-1M | $2M | $484.0K | $-10M | $-3.0K | $-3.0K | |
| Net Income | $-13M | $-15M | $-6M | $-6M | $570.0K | $-22M | $-4M | $10M | $-21M | $-8M | $-4M | $-4M | $-15M | $-5M | $-6M | |
| EPS (Basic) | $-0.54 | $-0.82 | $-0.33 | $-0.52 | $0.04 | $-5.38 | $-0.46 | $0.80 | $-0.61 | $0.11 | $-0.13 | $-0.29 | $-0.97 | $-0.35 | $-0.37 | |
| EPS (Diluted) | $-0.54 | $-0.77 | $-0.33 | $-0.52 | $-0.50 | $-3.08 | $-0.46 | $-1.50 | $-0.61 | $0.11 | $-0.13 | $-0.29 | $-0.97 | $-0.35 | $-0.37 | |
| Shares (Basic) | 23,908,153 | -131,299,383 | 18,065,389 | 12,302,059 | 11,681,881 | -40,899,981 | 8,894,321 | 3,791,481 | 34,912,692 | -38,560,741 | 32,633,074 | 15,234,570 | 15,232,406 | -30,038,252 | 15,061,995 | |
| Shares (Diluted) | 23,908,153 | -138,315,345 | 18,065,389 | 12,302,059 | 12,383,477 | -46,513,785 | 8,894,321 | 9,405,285 | 34,912,692 | -38,560,741 | 32,633,074 | 15,234,570 | 15,232,406 | -30,038,252 | 15,061,995 | |
| EBITDA | $-8M | · | $-7M | $-7M | $-8M | · | $-6M | $-7M | $-9M | · | $-6M | $-4M | · | · | $-6M |
Bilans 21
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37M | $29M | $43M | $22M | $20M | $26M | · | · | · | $10M | $14M | $19M | $24M | $455.0K | $7M | |
| Short-term Investments | $17M | $12M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory | · | · | · | · | · | · | · | · | · | · | · | $3M | $2M | · | $3M | |
| Prepaid Expense | $9M | $8M | $8M | $7M | $8M | $5M | $5M | $2M | $3M | $4M | $4M | $3M | · | $2M | · | |
| Current Assets | $64M | $49M | $50M | $30M | $27M | $31M | $38M | $44M | $52M | $13M | $19M | $22M | $26M | $3M | $10M | |
| PP&E (Net) | $48.0K | $66.0K | $75.0K | $83.0K | $83.0K | $75.0K | $61.0K | $43.0K | $23.0K | $26.0K | $28.0K | $30.0K | $21.0K | $22.0K | $24.0K | |
| PP&E (Gross) | $106.0K | $138.0K | $138.0K | $136.0K | $130.0K | $114.0K | $92.0K | $68.0K | $42.0K | $42.0K | $42.0K | $42.0K | $29.0K | $29.0K | $30.0K | |
| Accum. Depreciation | $58.0K | $72.0K | $63.0K | $53.0K | $47.0K | $39.0K | $31.0K | $25.0K | $19.0K | $16.0K | $14.0K | $12.0K | $8.0K | $7.0K | $6.0K | |
| Total Assets | $64M | $49M | $51M | $30M | $28M | $32M | $39M | $45M | $52M | $14M | $19M | $23M | $27M | $3M | $10M | |
| Accounts Payable | $1M | $383.0K | $957.0K | $775.0K | $1M | $1M | $548.0K | $1M | $1M | $839.0K | $1M | $503.0K | $790.0K | $892.0K | $2M | |
| Accrued Liabilities | $3M | $2M | $3M | $2M | $4M | $4M | $3M | $3M | $4M | $3M | $3M | $2M | $2M | $2M | $3M | |
| Current Liabilities | $26M | $19M | $13M | $14M | $17M | $24M | $10M | $13M | $30M | $18M | $15M | $15M | $16M | $3M | $6M | |
| Capital Leases | $217.0K | · | · | · | · | $117.0K | $265.0K | $274.0K | $372.0K | $466.0K | $552.0K | $634.0K | $715.0K | · | $29.0K | |
| Total Liabilities | $27M | $19M | $13M | $14M | $17M | $24M | $11M | $13M | $31M | $18M | $16M | $16M | $17M | $3M | $6M | |
| Common Stock | $25.0K | $22.0K | $21.0K | $122.0K | $120.0K | $11.0K | $98.0K | $43.0K | $37.0K | $35.0K | $35.0K | $15.0K | $15.0K | $15.0K | $15.0K | |
| Paid-in Capital | $178M | $158M | $151M | $123M | $112M | $109M | $107M | $61M | $61M | $61M | $60M | $33M | $33M | $34M | $33M | |
| Retained Earnings | $-141M | $-128M | $-113M | $-107M | $-101M | $-101M | $-80M | $-76M | $-86M | $-65M | $-57M | $-52M | $-49M | $-34M | $-29M | |
| AOCI | $6.0K | $-1.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $38M | $30M | $37M | $16M | $11M | $7M | $28M | $-15M | $-24M | $-4M | $3M | $-19M | $-15M | $-466.0K | $5M | |
| Liabilities + Equity | $64M | $49M | $51M | $30M | $28M | $32M | $39M | $45M | $52M | $14M | $19M | $23M | $27M | $3M | $10M | |
| Shares Outstanding | 25,237,782 | 22,114,245 | 20,850,363 | 14,111,852 | 119,749,743 | 11,384,236 | 97,858,406 | 43,573,212 | 37,606,630 | 34,756,049 | 34,754,401 | 15,236,016 | 15,233,836 | 15,231,655 | 15,087,943 |
Przepływy pieniężne 10
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $754.0K | $777.0K | $730.0K | $571.0K | $563.0K | $582.0K | $605.0K | $641.0K | $522.0K | $550.0K | $929.0K | $144.0K | $144.0K | $197.0K | $266.0K | |
| Operating Cash Flow | $-6M | $-8M | $-6M | $-8M | $-9M | $-7M | $-9M | $-6M | $-6M | $-4M | $-4M | $-6M | $-4M | $-6M | $-4M | |
| CapEx | $8.0K | $0 | $2.0K | $6.0K | $16.0K | $22.0K | $24.0K | $20.0K | $6.0K | $0 | $0 | · | · | $0 | $0 | |
| Investing Cash Flow | $-5M | $-12M | $-2.0K | $-6.0K | $-16.0K | $-22.0K | $-24.0K | $-20.0K | $-6.0K | $0 | $0 | · | · | $0 | $0 | |
| Stock Issued | · | · | · | · | · | · | · | $0 | $-4M | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $-4M | · | · | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | $0 | $0 | · | · | · | $100.0K | $600.0K | $200.0K | · | · | |
| Financing Cash Flow | $20M | $7M | $26M | $11M | $3M | $365.0K | $-157.0K | $-811.0K | $46M | $-205.0K | $-51.0K | $0 | $28M | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | $-6M | $24M | · | $-4M | |
| Free Cash Flow | $-6M | · | · | · | $-9M | · | · | · | $-6M | · | · | · | · | · | · |
Rentowność 5
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -584.0% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | -2159.3% | · | -584.3% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -584.0% | |
| ROA | -27.8% | · | -13.5% | -17.3% | 1.4% | · | -14.1% | 29.2% | -52.7% | · | -29.3% | -21.5% | -67.8% | · | -37.1% | |
| ROE | -52.4% | · | -18.4% | -814.5% | -8.6% | · | -26.2% | -57.6% | 106.0% | · | -108.1% | 81.1% | 1586.0% | · | -47.0% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | · | 3.8 | 2.2 | 1.6 | · | 3.6 | 3.4 | 1.7 | · | 1.2 | 1.4 | 1.6 | · | 1.8 | |
| Quick Ratio | 2.1 | · | 3.3 | 1.6 | 1.2 | · | · | · | · | · | 0.9 | 1.2 | 1.5 | · | 1.3 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -460.2 | · | -329.9 | -135.1 | · | · | -1851.3 |
Efektywność 1
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | 0.1 |
Wycena (TTM) 9
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-25M | · | $-16M | $-118.0K | $-15M | · | $-20M | $-19M | $-44M | · | $-28M | $-28M | $-27M | · | $-18M | |
| Market Cap | $166M | · | $91M | $67M | $689M | · | $399M | $218M | $519M | · | $299M | $195M | $320M | · | $89M | |
| P/E | -3.5 | · | -3.2 | -1.9 | -2.2 | · | -1.5 | -2.0 | -6.9 | · | -4.9 | -6.8 | -11.5 | · | -4.8 | |
| P/B | 4.4 | · | 2.4 | 4.1 | 61.1 | · | 14.3 | -14.7 | -21.2 | · | 88.2 | -10.1 | -21.2 | · | 19.2 | |
| P / Tangible Book | 4.4 | · | 2.4 | 4.1 | 61.1 | · | 14.3 | · | · | · | 88.2 | · | · | · | 19.2 | |
| P / Cash Flow | -26.6 | · | · | · | -77.3 | · | · | · | -80.4 | · | · | · | -81.6 | · | · | |
| P / FCF | -26.6 | · | · | · | -77.2 | · | · | · | -80.3 | · | · | · | · | · | · | |
| Earnings Yield | -28.7% | · | -31.2% | -53.0% | -45.6% | · | -66.2% | -50.5% | -14.5% | · | -20.5% | -14.6% | -8.7% | · | -20.7% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | · | · | -1.4% | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | — | — | $675.0K | $951.0K | — |
| Marża Operacyjna % | — | — | -3077.6% | -1898.2% | — |
| Zysk netto | $-27M | $-37M | $-31M | $-18M | $-10M |
| Rozwodniony EPS | $-1.67 | $-5.65 | $-1.28 | $-1.20 | $-0.86 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 2.6 | 1.3 | 0.8 | 0.8 | 8.7 |
| Wskaźnik Szybkości | 2.2 | 1.1 | 0.6 | 0.1 | 7.9 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-31M | $-29M | $-18M | $-16M | — |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.